Clinical features and underlying etiology of children with Lennox-Gastaut syndrome.
Autor: | Zhou Z; Department of Pediatrics, Peking University People's Hospital, Beijing, China.; Epilepsy Center, Peking University People's Hospital, Beijing, China., Jiao X; Department of Pediatrics, Peking University People's Hospital, Beijing, China.; Epilepsy Center, Peking University People's Hospital, Beijing, China., Gong P; Department of Pediatrics, Peking University First Hospital, Beijing, China., Niu Y; Department of Pediatrics, Peking University People's Hospital, Beijing, China.; Epilepsy Center, Peking University People's Hospital, Beijing, China., Xu Z; Department of Pediatrics, Peking University People's Hospital, Beijing, China.; Epilepsy Center, Peking University People's Hospital, Beijing, China., Zhang G; Department of Pediatrics, Peking University People's Hospital, Beijing, China.; Epilepsy Center, Peking University People's Hospital, Beijing, China., Zhang Y; Department of Pediatrics, Peking University First Hospital, Beijing, China., Qin J; Department of Pediatrics, Peking University People's Hospital, Beijing, China.; Epilepsy Center, Peking University People's Hospital, Beijing, China., Yang Z; Department of Pediatrics, Peking University People's Hospital, Beijing, China. zhixian.yang@163.com.; Epilepsy Center, Peking University People's Hospital, Beijing, China. zhixian.yang@163.com. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of neurology [J Neurol] 2024 Aug; Vol. 271 (8), pp. 5392-5401. Date of Electronic Publication: 2024 Jul 15. |
DOI: | 10.1007/s00415-024-12465-3 |
Abstrakt: | Objective: Lennox-Gastaut Syndrome (LGS) is characterized by the presence of multiple seizure types and encompasses a heterogenous group of etiologies. The aim of our study was to evaluate the etiological profile of LGS and investigate seizure outcomes based on different clinical variables. Methods: The clinical features, neuroimaging findings, genetic testing and other testing results of LGS patients were systematically reviewed. The identifiable etiology was categorized as either acquired or nonacquired. Univariate and multivariate regression analyses were performed to explore the association between clinical variables and seizure outcome at the last follow-up. Results: We enrolled 156 patients diagnosed with LGS, of whom 66% were male. The mean age of patients was 34.2 months and the median follow-up duration was 29.5 months (interquartile range = 14-56.25 months). The initial seizure type was epileptic spasm in 61 patients, among which 33 of them met the criteria for infantile epileptic spasm syndrome. All patients underwent neuroimaging test, with 25% falling into the acquired structural category. Etiology could be identified in 84 individuals, including pathogenetic variants found in 34 out of 117 patients with nonacquired etiology. CHD2 mutations were most frequently observed among these pathogenetic variants. At the last follow-up, favorable outcomes were observed in 27 patients. The identification of etiology emerged as a significant determinant influencing LGS outcome; specifically, patients with unknown etiology had a higher likelihood of experiencing favorable outcomes compared to those with known cause (p = 0.041). Early onset age and longer epilepsy duration significantly increased the odds of an unfavorable outcome (p = 0.006 and 0.024). Significance: We present novel data on the clinical and etiological spectrum of LGS, with determined etiology observed in over half of the patients. Epileptic spasms were found to be more prevalent than tonic seizures as seizure onset types in LGS. The presence of a known etiology, earlier age at onset, and longer duration of epilepsy were associated with a poorer long-term epileptological outcome. (© 2024. Springer-Verlag GmbH Germany, part of Springer Nature.) |
Databáze: | MEDLINE |
Externí odkaz: |